{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:54:33Z","timestamp":1694620473174},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,5,1]]},"DOI":"10.1038\/sj.bmt.1702388","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:36:02Z","timestamp":1031153762000},"page":"1017-1019","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High-dose therapy in breast cancer: out of favor but not out of promise"],"prefix":"10.1038","volume":"25","author":[{"given":"S","family":"Gl\u00fcck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,5,19]]},"reference":[{"key":"BF1702388_CR1","unstructured":"Autologous Blood and Marrow Transplant Registry Medical College of Wisconsin, Milwaukee, WI, 53226 USA 1996"},{"key":"BF1702388_CR2","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1995.13.10.2483","volume":"13","author":"WR Bezwoda","year":"1995","unstructured":"Bezwoda WR, Seymore L, Dansey RD . High-dose chemotherapy with hematopoietic rescue as primary treatment or metastatic breast cancer: a randomized trial J Clin Oncol 1995 13: 2483\u20132489","journal-title":"J Clin Oncol"},{"key":"BF1702388_CR3","unstructured":"Gl\u00fcck S, Crump M, Bociek G, Stewart D . High dose chemotherapy with autologous blood stem cell transplantation: increasing evidence for efficacy in patients with metastatic breast cancer. Autologous Blood and Marrow Transplantation Proceedings of the 9th International Symposium, Arlington, Texas 1999 pp 290\u2013302"},{"key":"BF1702388_CR4","first-page":"161a","volume":"18","author":"JP Lotz","year":"1999","unstructured":"Lotz JP, Cure H, Janvier M et al. High dose chemotherapy with hematopoietic stem cells transplantation for metastatic breast cancer: results of the French protocol PEGASE 04 Proc Am Soc Clin Oncol 1999 18: 161a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702388_CR5","first-page":"1a","volume":"18","author":"EA Stadtmauer","year":"1999","unstructured":"Stadtmauer EA, O'Neill A, Goldstein LJ et al. Phase III randomized trial of high dose chemotherapy and stem cell support shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil for women with metastatic breast cancer who are responding to conventional induction chemotherapy: the Philadelphia intergroup study (PBT-1) Proc Am Soc Clin Oncol 1999 18: 1a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702388_CR6","first-page":"149","volume":"15","author":"WP Peters","year":"1996","unstructured":"Peters WP, Jones RB, Vredenburgh J et al. A large, prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM) Proc Am Soc Clin Oncol 1996 15: 149","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702388_CR7","unstructured":"Gl\u00fcck S, Crump M . A randomised trial of high-dose chemotherapy and autologous stem cell therapy vs standard therapy in women with metastatic breast cancer who have responded to anthracycline or taxane-based induction chemotherapy, National Cancer Institute of Canada Clinical Trials Group. NCIC CTG Protocol Number MA. 16, 1997."},{"key":"BF1702388_CR8","first-page":"2a","volume":"18","author":"WP Peters","year":"1999","unstructured":"Peters WP, Rossner G, Vredenburgh J et al. A prospective randomized comparison of two doses of combination alkylating agents as consolidation after CAF in high risk primary breast cancer involving ten or more axillary lymph nodes: preliminary results of CALGB 9082 hSWOG9114 hNCICMA113 Proc Am Soc Clin Oncol 1999 18: 2a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702388_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1200\/JCO.1996.14.1.66","volume":"14","author":"M Crump","year":"1996","unstructured":"Crump M, Goss PE, Prince M, Girouard C . Outcome of extensive evaluation prior to adjuvant therapy in women with breast cancer and \u2a7e10 positive axillary nodes J Clin Oncol 1996 14: 66\u201369","journal-title":"J Clin Oncol"},{"key":"BF1702388_CR10","first-page":"3a","volume":"18","author":"9401 The Scandinavian Breast Cancer Stud","year":"1999","unstructured":"The Scandinavian Breast Cancer Study Group 9401 . Results from a randomized adjuvant breast cancer study with high-dose chemotherapy with CTCb supported by autologous bone marrow stem cells vs dose escalated and tailored FEC therapy Proc Am Soc Clin Oncol 1999 18: 3a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702388_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0140-6736(98)01350-6","volume":"325","author":"S Rodenhuis","year":"1998","unstructured":"Rodenhuis S, Richel DJ, van der Wall et al. Randomized trial of high dose chemotherapy and haematopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph node involvement Lancet 1998 325: 515\u2013521","journal-title":"Lancet"},{"key":"BF1702388_CR12","first-page":"471","volume":"17","author":"GN Hortobagyi","year":"1998","unstructured":"Hortobagyi GN, Buzdar AU, Champlin R, Gajewski J . Lack of efficacy of adjuvant high dose (HD) tandem combination chemotherapy (CT) for high risk primary breast cancer \u2013 a randomised trial Proc Am Soc Clin Oncol 1998 17: 471","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702388_CR13","first-page":"4a","volume":"18","author":"WR Bezwoda","year":"1999","unstructured":"Bezwoda WR . Randomized controlled trial of high dose chemotherapy versus standard dose chemotherapy for high risk, surgically treated primary breast cancer Proc Am Soc Clin Oncol 1999 18: 4a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702388_CR14","unstructured":"Rosti G . European Bone Marrow Transplantation Group Chair: solid tumors. Ravenna, Italy"},{"key":"BF1702388_CR15","unstructured":"A multicentre phase III randomised trial comparing docetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus TAC followed by high dose chemotherapy with mitoxantrone, cyclophosphamide and vinorelbine with autologous peripheral stem cell transplantation and G-CSF in adjuvant treatment of operable breast cancer with four or more positive axillary nodes. TAX 321 (BCIRG 002)"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702388","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T20:16:33Z","timestamp":1655237793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5,1]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,5,1]]}},"alternative-id":["BF1702388"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702388","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5,1]]},"assertion":[{"value":"1 October 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}